• 22. Januar 2025

New CELL Study presents groundbreaking pre-clinical work: immune therapy to potentially treat serious influenza A

ByHumabs BioMed

Juli 21, 2016
– MEDI8852 blocked all influenza A with unique binding properties
Teile den Beitrag mit Freunden